Effect of a synthetic cannabinoid agonist on the proliferation and invasion of gastric cancer cells

Journal of Cellular Biochemistry

Volumn 110, Issue 2, 2010, Pages 321-332

  Xian, Xiang Shu ^a   Park, Hyeyeon ^a   Cho, Yu Kyung ^a   Lee, In Seok ^a   Kim, Sang Woo ^a   Choi, Myung Gyu ^a   Chung, In Sik ^a   Han, Ki Hwan ^b   Park, Jae Myung ^a  

^a The Catholic University of Korea   (South Korea)

^b Ewha Womans University School of Medicine   (South Korea)

Author keywords

Apoptosis; Cannabinoid; Gastric cancer; Invasion; Proliferation

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; CANNABINOID 1 RECEPTOR; GELATINASE A; PROTEIN KINASE B; VASCULOTROPIN A;

ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL; CANCER THERAPY; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; DRUG EFFECT; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STOMACH CANCER;

APOPTOSIS; BASE SEQUENCE; BENZOXAZINES; CELL LINE, TUMOR; CELL PROLIFERATION; DNA PRIMERS; DOWN-REGULATION; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; MORPHOLINES; NAPHTHALENES; NEOPLASM INVASIVENESS; RECEPTOR, CANNABINOID, CB1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STOMACH NEOPLASMS;

EID: 77952063705     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22540     Document Type: Article

References (49)

1. Akopian AN, Ruparel NB, Jeske NA, Patwardhan A, Hargreaves KM. 2009. Role of ionotropic cannabinoid receptors in peripheral antinociception and antihyperalgesia. Trends Pharmacol Sci 30:79-84.
2. Asano M, Yukita A, Matsumoto T, Kondo S, Suzuki H. 1995. Inhibition of tumor growth and metastasis by an immunoneutralizing monoclonal antibody to human vascular endothelial growth factor/vascular permeability factor 121. Cancer Res 55:5296-5301.
3. Blázquez C, Salazar M, Carracedo A, Lorente M, Egia A, González-Feria L, Haro A, Velasco G, Guzmán M. 2008. Cannabinoids inhibit glioma cell invasion by down-regulating matrix metalloproteinase-2 expression. Cancer Res 68:1945-1952. (Pubitemid 351416581)
4. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J, Greenberg ME. 1999. Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor. Cell 96:857-868. (Pubitemid 29165088)
5. Cardone MH, Roy N, Stennicke HR, Salvesen GS, Franke TF, Stanbridge E, Frisch S, Reed JC. 1998. Regulation of cell death protease caspase-9 by phosphorylation. Science 282:1318-1321. (Pubitemid 28524494)
6. Carracedo A, Gironella M, Lorente M, Garcia S, Guzmán M, Velasco G, Iovanna JL. 2006a. Cannabinoids induce apoptosis of pancreatic tumor cells via endoplasmic reticulum stress-related genes. Cancer Res 66:6748-6755. (Pubitemid 44085633)
7. Carracedo A, Lorente M, Egia A, Blázquez C, García S, Giroux V, Malicet C, Villuendas R, Gironella M, González-Feria L, Piris MA, Iovanna JL, Guzmán M, Velasco G. 2006b. The stress-regulated protein p8 mediates cannabino-idinduced apoptosis of tumor cells. Cancer Cell 9:301-312.
8. Casanova ML, Blázquez C, Martínez-Palacio J, Villanueva C, Fernández- Aceñero MJ, Huffman JW, Jorcano JL, Guzmán M. 2003. Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors. J Clin Invest 111:43-50. (Pubitemid 36134847)
9. Cheng JQ, Lindsley CW, Cheng GZ, Yang H, Nicosia SV. 2005. The Akt/PKB pathway: Molecular target for cancer drug discovery. Oncogene 24:7482-7492. (Pubitemid 41637988)
10. Contassot E, Tenan M, Schnuriger V, Pelte MF, Dietrich PY. 2004. Arachidonyl ethanolamide induces apoptosis of uterine cervix cancer cells via aberrantly expressed vanilloid receptor-1. Gynecol Oncol 93:182-188. (Pubitemid 38429568)
11. Di Marzo V, Bifulco M, De Petrocellis L. 2004. The endocannabinoid system and its therapeutic exploitation. Nat Rev Drug Discov 3:771-784. (Pubitemid 39242829)
12. Egeblad M, Werb Z. 2002. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2:161-174. (Pubitemid 37328786)
13. Eichele K, Weinzierl U, Ramer R, Brune K, Hinz B. 2006. R(+)-methanandamide elicits a cyclooxygenase-2-dependent mitochondrial apoptosis signaling pathway in human neuroglioma cells. Pharm Res 23:90-94. (Pubitemid 43214664)
14. Ellert-Miklaszewska A, Kaminska B, Konarska L. 2005. Cannabinoids down-regulate PI3K/Akt and Erk signalling pathways and activate proapoptotic function of Bad protein. Cell Signal 17:25-37. (Pubitemid 39286777)
15. Fogli S, Nieri P, Chicca A, Adinolfi B, Mariotti V, Iacopetti P, Breschi MC, Pellegrini S. 2006. Cannabinoid derivatives induce cell death in pancreatic MIA PaCa-2 cells via a receptor-independent mechanism. FEBS Lett 580:1733-1739.
16. Giuliano M, Pellerito O, Portanova P, Calvaruso G, Santulli A, De Blasio A, Vento R, Tesoriere G. 2009. Apoptosis induced in HepG2 cells by the synthetic cannabinoid WIN: Involvement of the transcription factor PPAR-gamma. Biochimie 91:457-465.
17. Greenhough A, Patsos HA, Williams AC, Paraskeva C. 2007. The cannabinoid delta(9)-tetrahydrocannabinol inhibits RAS-MAPK and PI3K-AKT survival signalling and induces BAD-mediated apoptosis in colorectal cancer cells. Int J Cancer 121:2172-2180. (Pubitemid 47585595)
18. Grimaldi C, Pisanti S, Laezza C, Malfitano AM, Santoro A, Vitale M, Caruso MG, Notarnicola M, Iacuzzo I, Portella G, Di Marzo V, Bifulco M. 2006. Anandamide inhibits adhesion and migration of breast cancer cells. Exp Cell Res 312:363-373. (Pubitemid 41804104)
19. Gustafsson K, Christensson B, Sander B, Flygare J. 2006. Cannabinoid receptor-mediated apoptosis induced by R(+)-methanandamide and Win 55, 212-2 is associated with ceramide accumulation and p38 activation in mantle cell lymphoma. Mol Pharmacol 70:1612-1620.
20. Guzmán M. 2003. Cannabinoids: Potential anticancer agents. Nat Rev Cancer 3:745-755.
21. Hall W, Christie M, Currow D. 2005. Cannabinoids and cancer: Causation, remediation, and palliation. Lancet Oncol 6:35-42.
22. Hinz B, Ramer R, Eichele K, Weinzierl U, Brune K. 2004. Up-regulation of cyclooxygenase-2 expression is involved in R(+)-methanandamide-induced apoptotic death of human neuroglioma cells. Mol Pharmacol 66:1643-1651. (Pubitemid 39564792)
23. Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, Devane WA, Felder CC, Herkenham M, Mackie K, Martin BR, Mechoulam R, Pertwee RG. 2002. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev 54:161-202.
24. Joseph J, Niggemann B, Zaenker KS, Entschladen F. 2004. Anandamide is an endogenous inhibitor for the migration of tumor cells and T lymphocytes. Cancer Immunol Immunother 53:723-728. (Pubitemid 38962066)
25. Kanai T, Konno H, Tanaka T, Baba M, Matsumoto K, Nakamura S, Yukita A, Asano M, Suzuki H, Baba S. 1998. Anti-tumor and anti-metastatic effects of human-vascular-endothelial-growth-factor-neutralizing antibody on human colon and gastric carcinoma xenotransplanted orthotopically into nude mice. Int J Cancer 77:933-936. (Pubitemid 28378146)
26. Karayiannakis AJ, Syrigos KN, Polychronidis A, Zbar A, Kouraklis G, Simopoulos C, Karatzas G. 2002. Circulating VEGF levels in the serum of gastric cancer patients: Correlation with pathological variables, patient survival, and tumor surgery. Ann Surg 236:37-42. (Pubitemid 34686448)
27. Kondo K, Kaneko T, Baba M, Konno H. 2007. VEGF-C and VEGF-A synergistically enhance lymph node metastasis of gastric cancer. Biol Pharm Bull 30:633-637. (Pubitemid 46570975)
28. Lee YM, Uhm KO, Lee ES, Kwon J, Park SH, Kim HS. 2008. AM251 suppresses the viability of HepG2 cells through the AMPK (AMP-activated protein kinase)-JNK (c-Jun N-terminal kinase)-ATF3 (activating transcription factor 3) pathway. Biochem Biophys Res Commun 370:641-645.
29. Ligresti A, Bisogno T, Matias I, De Petrocellis L, Cascio MG, Cosenza V, D'argenio G, Scaglione G, Bifulco M, Sorrentini I, Di Marzo V. 2003. Possible endocannabinoid control of colorectal cancer growth. Gastroenterology 125:677-687.
30. Ligresti A, Moriello AS, Starowicz K, Matias I, Pisanti S, De Petrocellis L, Laezza C, Portella G, Bifulco M, Di Marzo V. 2006. Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma. J Pharmacol Exp Ther 318:1375-1387. (Pubitemid 44268348)
31. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI. 1990. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346:561-564. (Pubitemid 20238806)
32. McCawley LJ, Matrisian LM. 2001. Tumor progression: Defining the soil round the tumor seed. Curr Biol 11:R25-27.
33. Miyato H, Kitayama J, Yamashita H, Souma D, Asakage M, Yamada J, Nagawa H. 2009. Pharmacological synergism between cannabinoids and paclitaxel in gastric cancer cell lines. J Surg Res 155:40-47.
34. Munro S, Thomas KL, Abu-Shaar M. 1993. Molecular characterization of a peripheral receptor for cannabinoids. Nature 365:61-65. (Pubitemid 23305569)
35. Munson AE, Harris LS, Friedman MA, Dewey WL, Carchman RA. 1975. Antineoplastic activity of cannabinoids. J Natl Cancer Inst 55:597-602.
36. Nithipatikom K, Endsley MP, Isbell MA, Falck JR, Iwamoto Y, Hillard CJ, Campbell WB. 2004. 2-arachidonoylglycerol: A novel inhibitor of androgenin-dependent prostate cancer cell invasion. Cancer Res 64:8826-8830. (Pubitemid 39665485)
37. Nithipatikom K, Endsley MP, Isbell MA, Wheelock CE, Hammock BD, Campbell WB. 2005. A new class of inhibitors of 2-arachidonoylglycerol hydrolysis and invasion of prostate cancer cells. Biochem Biophys Res Commun 332:1028-1033. (Pubitemid 40798189)
38. Nomura H, Fujimoto N, Seiki M, Mai M, Okada Y. 1996. Enhanced production of matrix metalloproteinases and activation of matrix metalloproteinase 2 (gelatinase A) in human gastric carcinomas. Int J Cancer 69:9-16. (Pubitemid 26083264)
39. Oesch S, Walter D, Wachtel M, Pretre K, Salazar M, Guzmán M, Velasco G, Schäfer BW. 2009. Cannabinoid receptor 1 is a potential drug target for treatment of translocation-positive rhabdomyosarcoma. Mol Cancer Ther 8:1838-1845.
40. Overall CM, Kleifeld O. 2006. Tumour microenvironment-opinion: Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy. Nat Rev Cancer 6:227-239.
41. Patsos HA, Hicks DJ, Dobson RR, Greenhough A, Woodman N, Lane JD, Williams AC, Paraskeva C. 2005. The endogenous cannabinoid, anandamide, induces cell death in colorectal carcinoma cells: A possible role for cyclooxygenase 2. Gut 54:1741-1750. (Pubitemid 41697674)
42. Pazos MR, Tolón RM, Benito C, Rodríguez CF, Gorgojo JJ, Nevado M, Alvarez M, Arias F, Almodóvar F, Fernández MT, Lledó JL, González S, Fernández- Ruiz JJ, Romero J. 2008. Cannabinoid CB1 receptors are expressed by parietal cells of the human gastric mucosa. J Histochem Cytochem 56: 511-516. (Pubitemid 351556493)
43. Pi-Sunyer FX, Aronne LJ, Heshmati HM, Devin J, Rosenstock J. 2006. Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: A randomized controlled trial. JAMA 295:761-775. (Pubitemid 43244304)
44. Portella G, Laezza C, Laccetti P, De Petrocellis L, Di Marzo V, Bifulco M. 2003. Inhibitory effects of cannabinoid CB1 receptor stimulation on tumor growth and metastatic spreading: Actions on signals involved in angiogenesis and metastasis. FASEB J 17:1771-1773.
45. Ramer R, Hinz B. 2008. Inhibition of cancer cell invasion by cannabinoids via increased expression of tissue inhibitor of matrix metalloproteinases-1. J Natl Cancer Inst 100:59-69. (Pubitemid 351767340)
46. Rundhaug JE. 2005. Matrix metalloproteinases and angiogenesis. J Cell Mol Med 9:267-285.
47. Saito H, Tsujitani S, Kondo A, Ikeguchi M, Maeta M, Kaibara N. 1999. Expression of vascular endothelial growth factor correlates with hematogenous recurrence in gastric carcinoma. Surgery 125:195-201. (Pubitemid 29076116) (Pubitemid 29076116)
48. Sarfaraz S, Afaq F, Adhami VM, Malik A, Mukhtar H. 2006. Cannabinoid receptor agonist-induced apoptosis of human prostate cancer cells LNCaP proceeds through sustained activation of ERK1/2 leading to G1 cell cycle arrest. J Biol Chem 281:39480-39491. (Pubitemid 46041908)
49. Sarfaraz S, Afaq F, Adhami VM, Mukhtar H. 2005. Cannabinoid receptor as a novel target for the treatment of prostate cancer. Cancer Res 65:1635-1641. (Pubitemid 40478586)